Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Explore methods to stay financially stable mid-month, including disciplined review and targeted adjustments that protect your budget.
23,913 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Investors weigh if dividend income can replace a $110,000 salary through yields and risk. A blended retirement plan i...
U.S. adults now smoke at a record low, but a shift in public-health funding threatens the playbook that drove the dec...
Wall Street embraces a bold forecast for humanoid robots and the physical AI stack, fueling fresh bets on Nvidia, Tes...
A clear guide to the latest ANIP quarterly update. We unpack the numbers, translate management commentary into real-w...
Bitcoin retreated below the 70,000 level for a second straight session, dragging Strategy and Coinbase lower as marke...
The White House has tapped a real-estate heir as acting director of national intelligence, a move that drew sharp que...
Strategy disclosed a record unrealized loss on its Bitcoin holdings, topping $10 billion as bitcoin trades near $61,0...
Tech stocks retreat as chipmakers drag the Nasdaq lower and rising yields weigh on growth names after a stronger jobs...
A historic moment could unfold as trump will first sitting president attends a Knicks Finals game, with potential kno...
CoreWeave trades around $100 as a massive backlog tests cash-generation prospects. Q1 results show strong revenue gro...
The Gedalje Group climbs to the top 10 in RealTrends' 2026 The Thousand rankings after closing 468 sides and $245 mil...